SPDR® MSCI Europe Health Care UCITS ETF STWX IM

Equity securities may fluctuate in value in response to the activities of individual companies and general market and economic conditions.

ETFs trade like stocks, are subject to investment risk, fluctuate in market value and may trade at prices above or below the ETFs net asset value. Brokerage commissions and ETF expenses will reduce returns.

Investing in foreign domiciled securities may involve risk of capital loss from unfavorable fluctuation in currency values, withholding taxes, from differences in generally accepted accounting principles or from economic or political instability in other nations.

NAV EUR (Official NAV)

€185,51

as of 22 Mar 2023

Base Fund Currency

EUR

1 Day Nav Change

+€0,30 (+0,16%)

as of 22 Mar 2023

Assets Under Management

€610,22 M

as of 22 Mar 2023

TER

0,18%

as of 28 Feb 2023

Quick Links

Fund Objective

The investment objective of the Fund is to track the performance of European large and mid-sized companies in the Health Care sector.

Index Description

The MSCI Europe Health Care 35/20 Capped Index is a free float-adjusted market capitalization weighted index that is designed to measure the equity market performance of constituents classified as Health Care (according to the Global Industry Classification Standard) in the MSCI Europe index.

Fund Information as of 23 Mar 2023

ISIN	IE00BKWQ0H23
iNAV Ticker	INSTW
Inception Date	05 Dec 2014
Countries of Registration	Austria, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, Netherlands, Norway, Spain, Sweden, Switzerland, United Kingdom
Base Fund Currency	EUR
Income Treatment	Accumulation
Settlement Cycle	Redemption Settlement Cycle, DD+2; Subscription Settlement Cycle, DD+2
Trading Cycle	DD
TER	0,18%
Benchmark	MSCI Europe Health Care 35/20 Capped Index
Minimum Investment	1 Share
Trading Currency	CHF, EUR, GBP, MXN
UCITS Compliant	Yes
Domicile	Ireland
Investment Manager	State Street Global Advisors Europe Limited
Sub-Investment Manager(s)	State Street Global Advisors Limited
Fund Umbrella	SSGA SPDR ETFs Europe II plc
Replication Method	Replicated
Distribution Frequency	-
PEA Eligible	No
ISA Eligible	Yes
SIPP Eligible	Yes
UK Reporting Status	Yes
Securities Lending	Yes

Listing and Ticker Information as of 23 Mar 2023

Exchange	Trading Currency	Listing Date	Exchange Ticker	SEDOL Code	Bloomberg Code	Reuters Code
Euronext Paris (Primary)	EUR	08 Dec 2014	STW	BM67JF6	STW FP	STW.PA
SIX Swiss Exchange	CHF	09 Dec 2014	STWX	BM67JH8	STWX SE	STWX.S
Deutsche Börse	EUR	09 Dec 2014	SPYH	BKX4075	SPYH GY	SPYH.DE
London Stock Exchange	EUR	09 Dec 2014	HLTH	BSBNC41	HLTH LN	HLTH.L
Borsa Italiana	EUR	10 Dec 2014	STWX	BM67JG7	STWX IM	STWX.MI
Bolsa Mexicana de Valores	MXN	12 Feb 2019	HLTHN	BJCWGN1	HLTHN MM	HLTHN.MX
London Stock Exchange	GBP	04 Apr 2022	HEAE	BKWQ0H2	HEAE LN	HEAE.L

INAV

Estimated NAV per Unit at 4PM, Hong Kong as of
Estimated NAV per Unit as of (Updated every 15 seconds)

As of (Updated every 15 seconds)
INAV TICKER	CURRENCY	INAV

The Indicative NAV per share should not be viewed as the actual NAV per share. The Indicative NAV per share is provided for reference purposes only and may differ from the actual NAV per share calculated in accordance with the Prospectus.

Fund Characteristics as of 21 Mar 2023

Average Market Cap (M)	€127 586,27 M
Number of Holdings	40
Average Price/Book	3,50
Price/Earnings Ratio FY1	16,16

Index Characteristics as of 21 Mar 2023

Index Dividend Yield

2,51%

Fund Market Price as of 22 Mar 2023

Bid Price	€184,32
Offer Price	€186,64
Closing Price	€185,32
Bid/Offer Spread	€2,32
Day High	€185,56
Day Low	€185,32
52 Week High	€210,55
52 Week Low	€169,78

Fund Net Asset Value as of 22 Mar 2023

NAV EUR (Official NAV)	€185,51
NAV CHF	CHF 184,90
NAV GBP	£163,67
NAV MXN	MXN $3 709,70
Assets Under Management	€610,22 M
Shares in Issue	3 289 500

Most Recent NAV/NAV History

Reference NAVs are calculated for information purposes only. No warranty is provided as to the accuracy of reference NAVs. Reference NAVs are calculated with WM1600 FX (London time) rate applied in the currency indicated.

Fund Performance

Fund Inception Date: 05 Dec 2014
Index Inception Date: 07 May 2020
Performance Inception Date: 30 Sep 2001

as of 28 Feb 2023

	As Of	1 Month	3 Month	YTD	1 Year	3 Year	5 Year	10 Year	Since Inception 30 Sep 2001
Fund Net	28 Feb 2023	0,36%	-1,54%	0,38%	1,11%	23,68%	62,14%	128,64%	227,66%
Difference	28 Feb 2023	0,00%	-0,04%	-0,02%	-0,09%	-0,35%	-0,89%	-3,00%	-18,04%
Fund Gross	28 Feb 2023	0,38%	-1,49%	0,41%	1,30%	24,53%	64,24%	135,10%	254,80%
Difference	28 Feb 2023	0,01%	0,01%	0,00%	0,10%	0,50%	1,21%	3,46%	9,09%
Index	28 Feb 2023	0,37%	-1,50%	0,41%	1,20%	24,03%	63,03%	131,64%	245,71%

as of 28 Feb 2023

	As Of	1 Month	3 Month	YTD	1 Year	3 Year	5 Year	10 Year	Since Inception 30 Sep 2001
Fund Net	28 Feb 2023	0,36%	-1,54%	0,38%	1,11%	7,35%	10,15%	8,62%	5,70%
Difference	28 Feb 2023	0,00%	-0,04%	-0,02%	-0,09%	-0,10%	-0,12%	-0,14%	-0,26%
Fund Gross	28 Feb 2023	0,38%	-1,49%	0,41%	1,30%	7,59%	10,43%	8,93%	6,09%
Difference	28 Feb 2023	0,01%	0,01%	0,00%	0,10%	0,14%	0,16%	0,16%	0,13%
Index	28 Feb 2023	0,37%	-1,50%	0,41%	1,20%	7,45%	10,27%	8,76%	5,96%

as of 28 Feb 2023

	2023 (YTD)	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Fund Net	0,38%	-4,46%	25,32%	-2,05%	31,62%	-0,70%	2,75%	-9,49%	14,77%	19,11%	25,31%
Difference	-0,02%	-0,08%	-0,11%	-0,15%	-0,15%	-0,12%	-0,12%	-0,11%	-0,26%	-0,17%	-0,29%
Fund Gross	0,41%	-4,29%	25,61%	-1,76%	32,02%	-0,40%	3,05%	-9,22%	15,12%	19,47%	25,68%
Difference	0,00%	0,09%	0,18%	0,15%	0,24%	0,18%	0,19%	0,16%	0,09%	0,19%	0,09%
Index	0,41%	-4,38%	25,43%	-1,90%	31,77%	-0,58%	2,86%	-9,38%	15,03%	19,28%	25,59%

Performance Gross and Net of All Fees.

Past performance is not an indicator of future performance. The Gross of fees do not reflect and net of fees do reflect commissions and costs incurred on the issue and redemption, or purchases and sale, of units. If the performance is calculated on the basis of Gross/net asset values that are not denominated in the accounting currency of the collective investment scheme, its value may rise or fall as a result of currency fluctuations.

Calendar year inception performance returns will be partial for the year where the inception date for either the Fund in question or the historic performance-linked Fund (whichever is the earliest) falls within that period.

Deviation & Tracking Error as of 28 Feb 2023

Standard Deviation	14,02%
Tracking Error	0,15%

This calculation is based on the past 3 years performance information.

Top Holdings

Fund Top Holdings as of 21 Mar 2023

Security Name	Weight
Novo Nordisk A/S Class B	16,30%
AstraZeneca PLC	13,93%
Roche Holding Ltd Dividend Right Cert.	13,51%
Novartis AG	12,18%
Sanofi	7,49%
GSK plc	4,79%
Bayer AG	4,09%
EssilorLuxottica SA	3,45%
Lonza Group AG	2,92%
Alcon AG	2,27%

Download All Holdings: Download Daily Holdings

Industry Allocation

Fund Industry Allocation as of 21 Mar 2023

Sector	Weight
Pharmaceuticals	76,30%
Health Care Equipment & Supplies	12,93%
Life Sciences Tools & Services	5,75%
Biotechnology	3,45%
Health Care Providers & Services	1,57%

Geographical Weights

Documents

Fund Documents

Information & Schedules

Characteristics, holdings and sectors shown are as of the date indicated and are subject to change. This information should not be considered a recommendation to invest in a particular sector or to buy or sell any security shown. It is not known whether the sectors or securities shown will be profitable in the future. The holdings are taken from the accounting records of SSGA which may differ from the official books and records of the custodian.

Capital Risk: Investing involves risk including the risk of loss of capital.

Past performance is not a reliable indicator of future performance.

First net asset value taken into account corresponds to the first end of month following complete investment of the portfolio in agreement with the policy of management. Historical performance is not necessarily indicative of actual future investment performance.

The financial products referred to herein are not sponsored, endorsed, or promoted by MSCI and MSCI bears no liability with respect to any such financial products or any index on which such financial products are based. The Prospectus contains a more detailed description of the limited relationship MSCI has with SSGA and any related financial products.

Previous to 1 December 2020, this Fund's Benchmark was the MSCI Europe Health Care Index.

The recipient is only permitted to view or receive the Index Data in the form in which it is in presented. The recipient understands, acknowledges and agrees that use of the Index Data is at its sole risk. The recipient understands, acknowledges and agrees that the Index Data is provided "as is" and that neither Morningstar UK Limited (Morningstar) nor its content providers warrant the accuracy, completeness, non-infringement, originality, timeliness or any other characteristic of the Index Data. The recipient further understands, acknowledges and agrees that the Index Data is provided to you as an investor in financial products solely pursuant to regulatory requirements and for informational purposes only. The Index Data may not be used by you for commercial purposes and may not be used for trading or other purposes in lieu of a subscription to such Index Data with Morningstar.